Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

The compound (1R,2S)-4-(2-Cyano-cyclohexyl-oxy)-2-trifluoromethyl-benzonitrile can stimulate hair growth and reduce oil production when applied topically.

The compound GD-23 may reduce anxiety like diazepam by targeting the TSPO receptor.

The new formulation greatly improved quercetin absorption in rats.

PF-998425 is a new, effective, and non-phototoxic treatment for skin conditions related to androgens.

Some newly made compounds are promising for treating enlarged prostate, hair loss, viruses, and prostate cancer, and might be better than current drugs.

Compound 1 showed promising anticancer activity.

The new compound may be a safer alternative to finasteride for prostate protection.

Squaric acid dibutylester can cause severe skin reactions in people with allergies.

New compounds show promise as nonsteroidal treatments for hair loss.

Compound 15a was effective in inhibiting 5α-reductase.

The side gland of Suncus murinus is a good model for studying human sebaceous glands.

Scientists made a chemical (compound 4e) that can be applied on skin to reduce oil production, which can help with acne, but it might cause skin sensitivity to light.

Squaric acid dibutylester for alopecia areata can cause benign skin lymphoid growths.

DS-2325a is safe and well-tolerated, supporting further development for Netherton Syndrome treatment.

A brominated phenoxy compound effectively inhibits a human enzyme and shows potential for clinical use.

New chemicals were made that can block an enzyme linked to hair loss, prostate growth, and acne.

Compounds 15, 20, and 25 are strong inhibitors of human steroid 5α-reductase type 2.

Finasteride reduces certain behaviors caused by D1-like receptor agonists but not by D2-like receptor agonists in mice.

Compounds 4, 4b, and 4c effectively inhibit an enzyme linked to testosterone conversion without significant toxicity.

SARMs show promise but need more evidence to prove they're better than traditional androgens.

GD-23 reduces anxiety by relying on neurosteroid production.

The nature of the side chain in RU 58841 derivatives greatly affects its AR affinity, with the N-(iodopropenyl) derivative 13 showing the highest AR binding affinity, suggesting its potential for developing high-affinity radioiodinated AR radioligands.

MK-0773 is a moderate inhibitor of the SRD5A2 enzyme.

Certain inhibitors can potentially treat prostate cancer and other hormone-dependent conditions by controlling sex hormone levels in cells.

2-Hydroxy-1,4-naphthoquinone is a strong 5α-reductase inhibitor.

A compound made by Pfizer can potentially stimulate hair growth and reduce oil production, making it a good candidate for topical use.

A new, efficient method creates sulfinimidate esters from sulfenamides and alcohols without metals.

Hexahydrobenzo[f]quinolines are effective at blocking the enzyme 5α-reductase.